Who invested in Prgnos?
Prgnos's investors include Merck Global Health Innovation Fund, Hikma Ventures, Cigna, GISm Hermed and Maywic, and 1 more on record.
United States · Series C startup
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$21Mraised across 1 round since 2017, from 1 source
Reported by FinSMEs
Prgnos's investors include Merck Global Health Innovation Fund, Hikma Ventures, Cigna, GISm Hermed and Maywic, and 1 more on record.
Prgnos has raised $21M across 1 round since 2017.
Prgnos's most recent round was a Series C of $21M in Dec 2017.
Its most recent round, $21M in Dec 2017, is also its largest on record.
Prgnos's first round on record, in Dec 2017, was backed by Merck Global Health Innovation Fund, Hikma Ventures and Cigna and 3 others.
Prgnos's latest named round is a Series C, in Dec 2017.
Prgnos is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.